Shares of Bacterin's common stock receive approval for listing on NYSE Amex

Bacterin International Holdings, Inc. (OTC Bulletin Board: BIHI) ("Bacterin"), a creator and developer of revolutionary bone graft material and anti-infective coatings for medical applications, today announced that its common stock has been approved for listing on the NYSE Amex and has chosen Knight Capital Group as its designated market maker.  Shares of Bacterin's common stock will commence trading on the NYSE Amex on Monday, March 7, 2011 under the new ticker symbol "BONE".

"This is truly an eventful period in our company's history as we proudly commence the trading of our stock on the NYSE Amex.  We believe our shares will experience higher liquidity as a NYSE Amex listed company, which will raise our profile in the investment community," said Guy Cook, founder and CEO of Bacterin.  "Over 12 years ago, we launched Bacterin with the goal to create interventional therapeutic products that encourage surgeons to treat patients earlier in the disease cascade.  As a result, our core technology in both biological scaffolds for tissue regeneration and antimicrobial coatings offers patients faster, safer and more effective healing results at a greatly reduced overall cost to the medical provider.  Today we have an increasing commercialized product portfolio uniquely addressing current trends and needs within the healthcare industry."

"We welcome Bacterin International Holdings, Inc. to the NYSE Euronext family of listed companies and to NYSE Amex," said Scott Cutler, EVP and Co-Head of U.S. Listings and Cash Execution, NYSE Euronext.  "Bacterin and its shareholders will benefit from superior market quality and technology, a broad array of issuer and investor services, and a global brand association.  We look forward to building a strong and lasting partnership with the Company and its shareholders."

Prior to the listing of its common stock under ticker symbol BONE on the NYSE Amex on March 7, 2011, Bacterin's common stock will continue to trade under the symbol BIHI.OB on the OTC Bulletin Board.

SOURCE Bacterin International Holdings, Inc.